Prevention knowledge, risk behaviours and seroprevalence among nonurban injectors of southwest Connecticut
- PMID: 27073014
- PMCID: PMC5031506
- DOI: 10.1111/dar.12396
Prevention knowledge, risk behaviours and seroprevalence among nonurban injectors of southwest Connecticut
Abstract
Introduction and aims: Little is known about injection-associated risk behaviours, knowledge and seroprevalence of viral infections among people who inject drugs (PWID) in nonurban locales in the US. Harm reduction services are more available in urban locales. The present study examined a cohort of active PWID residing in non urban areas of Connecticut to investigate how primarily injecting in urban or non urban areas was associated with injection-associated risk behaviours, knowledge and prevalence of blood-borne viruses.
Design and methods: We described the sample and performed bivariate and multivariable analyses on injection-associated risk behaviours, HIV/hepatitis/overdose knowledge and baseline serological data to identify differences between individuals who injected primarily in nonurban locales and those who did not.
Results: Harm reduction knowledge and use of harm reduction services were poor in both groups. Those injecting most often in urban settings were 1.88 (1.19, 2.98 95% confidence interval) times more likely to engage in at least one injection-associated risk behaviour than their nonurban counterpart. Seroprevalence rates (23.6% for hepatitis B virus, 39.2% for hepatitis C virus, and 1.1% for HIV) were no different between the two groups.
Discussion and conclusions: The data provided little evidence that the benefits of urban harm reduction programs, such as syringe exchange, risk reduction interventions and education programs have penetrated into this nonurban population, even among those who injected in urban locales where such programs exist. Harm reduction interventions for nonurban communities of PWID are needed to reduce HIV and hepatitis B and C transmission. [Grau LB, Zhan W, Heimer R. Prevention knowledge, risk behaviours and seroprevalence among nonurban injectors of southwest Connecticut. Drug Alcohol Rev 2016;35:628-636].
Keywords: HIV/AIDS; hepatitis; injection drug use; prevalence; risk.
© 2016 Australasian Professional Society on Alcohol and other Drugs.
Conflict of interest statement
There are no declarations of competing interests for any of the authors.
Similar articles
-
Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia.Afr J AIDS Res. 2018 Sep;17(3):259-264. doi: 10.2989/16085906.2018.1511604. Epub 2018 Oct 14. Afr J AIDS Res. 2018. PMID: 30319040
-
Seroprevalence of HIV, hepatitis B virus, and HCV among injection drug users in Connecticut: understanding infection and coinfection risks in a nonurban population.Am J Public Health. 2014 Sep;104(9):1713-21. doi: 10.2105/AJPH.2013.301357. Epub 2013 Oct 17. Am J Public Health. 2014. PMID: 24134382 Free PMC article.
-
Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.Int J Drug Policy. 2017 Sep;47:9-17. doi: 10.1016/j.drugpo.2017.06.006. Epub 2017 Jul 3. Int J Drug Policy. 2017. PMID: 28683432 Free PMC article.
-
Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.Int J Drug Policy. 2014 Jan;25(1):34-52. doi: 10.1016/j.drugpo.2013.07.001. Epub 2013 Aug 21. Int J Drug Policy. 2014. PMID: 23973009 Review.
-
Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis.Int J Drug Policy. 2019 Aug;70:87-93. doi: 10.1016/j.drugpo.2019.05.005. Epub 2019 May 21. Int J Drug Policy. 2019. PMID: 31125802 Free PMC article.
Cited by
-
Knowledge of hepatitis C and treatment willingness amongst people who inject drugs in an era of direct acting antivirals.Int J Drug Policy. 2017 Sep;47:137-143. doi: 10.1016/j.drugpo.2017.02.006. Epub 2017 Mar 24. Int J Drug Policy. 2017. PMID: 28347636 Free PMC article.
-
Injection drug use, HIV/HCV, and related services in nonurban areas of the United States: A systematic review.Drug Alcohol Depend. 2018 Jul 1;188:239-250. doi: 10.1016/j.drugalcdep.2018.03.049. Epub 2018 May 8. Drug Alcohol Depend. 2018. PMID: 29787966 Free PMC article.
-
Development, validation, and potential applications of the hepatitis C virus injection-risk knowledge scale (HCV-IRKS) among young opioid users in New York City.Drug Alcohol Depend. 2019 Jan 1;194:453-459. doi: 10.1016/j.drugalcdep.2018.11.010. Epub 2018 Nov 28. Drug Alcohol Depend. 2019. PMID: 30503906 Free PMC article.
-
Factors associated with receptive injection equipment sharing among people who inject drugs: findings from a multistate study at the start of the COVID-19 pandemic.Harm Reduct J. 2023 Feb 15;20(1):18. doi: 10.1186/s12954-023-00746-5. Harm Reduct J. 2023. PMID: 36793041 Free PMC article.
-
Potential impact of curative and preventive interventions toward hepatitis C elimination in people who inject drugs-A network modeling study.Int J Drug Policy. 2024 Aug;130:104539. doi: 10.1016/j.drugpo.2024.104539. Epub 2024 Jul 20. Int J Drug Policy. 2024. PMID: 39033645 Free PMC article.
References
-
- Calefati J. Heroin hits the suburbs-hard. A sad trail of abuse is spreading beyond the Northeast’s inner cities. US News & World Report. 2008;145:27–8. - PubMed
-
- Cicero TJ, Surratt H, Inciardi JA, Munoz A. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. Pharmacoepidem Dr S. 2007;16:827–40. - PubMed
-
- Watson CA, Weng CX, French T, Anderson BJ, Nemeth C, McNutt LA, et al. Substance abuse treatment utilization, HIV risk behaviors, and recruitment among suburban injection drug users in Long Island, New York. AIDS Behav. 2014;18(Supp 3):S305–15. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical